Scientists track breast cancer's evolution to outsmart drug resistance

NCT ID NCT03758976

First seen Oct 31, 2025 · Last updated Jun 10, 2026 · Updated 33 times

Summary

This study is observing 2,000 people with advanced breast cancer to learn how the disease changes and becomes resistant to treatments. Researchers will analyze tumor samples and track health outcomes over time. The goal is to find better ways to predict and treat metastatic breast cancer, but this study does not test a new treatment itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lund University Hospital

    RECRUITING

    Lund, 221 85, Sweden

  • Lund University Hospital

    RECRUITING

    Lund, 221 85, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.